Record Details

Anaesthesia of roan antelope (Hippotragus equinus) with a combination of A3080, medetomidine and ketamine

Journal of the South African Veterinary Association


 
 
Field Value
 
Title Anaesthesia of roan antelope (Hippotragus equinus) with a combination of A3080, medetomidine and ketamine
 
Creator Citino, S.B. Bush, M. Grobler, D. Lance, W.
 
Subject — A3080; Anaesthesia; Atipamezole; Hippotragus Equinus; Ketamine; Medetomidine; Naltrexone; Roan Antelope
Description A dose range was determined for anaesthesia of 20 recently boma-captured roan antelope (Hippotragus equinus) with the synthetic opiate A3080 combined with medetomidine and ketamine. A dose of 10-30 µ/kg A3080 (x = 20 ± 8 µg/kg) combined with 5-21 µg/kg medetomidine (x = 13 ± 7 µg/kg) plus 0.29-1.11 mg/kg ketamine (x = 0.71 ± 0.24 mg/kg) was found to be safe and effective for the field conditions in this study. The anaesthesia produced by this drug combination was predictable and characterised by a short induction time, good muscle relaxation, and acceptable physiological parameters for anaesthesia periods ranging from 49-103 min (x = 64 ±19 min). The wide range (3-4-fold) of doses with acceptable results is also an indication that this drug combination has a wide margin of safety in roan antelope, making it desirable for field use. When 2 dose levels (2-3-fold difference) were retrospectively evaluated, no statistical difference was found in induction times, and no observable clinical differences in the anaesthetic episodes were seen. Based on this study, the recommended dose range in roan antelope for this combination is 10-13 µg/kg A3080, 5-6 µg/kg medetomidine and 0.3-0.6 mg/kg ketamine. The anaesthesia produced by this combination was rapidly and completely reversed by i.m. or i.v. injections of naltrexone at 30 times the A3080 dose (x = 0.60 ± 0.25 mg/kg) and atipamezole at 3 times the medetomidine dose (x = 38 ± 20 µg/kg). No residual effects from ketamine were noted following reversal of A3080 and medetomidine. No mortality was associated with this protocol.
 
Publisher AOSIS Publishing
 
Contributor
Date 2001-07-09
 
Type — —
Format application/pdf
Identifier 10.4102/jsava.v72i1.605
 
Source Journal of the South African Veterinary Association; Vol 72, No 1 (2001); 29-32
 
Language en
 
Coverage — — —
Rights Copyright information Ownership of copyright in terms of the Work remains with the authors. The authors retain the non-exclusive right to do anything they wish with the Work, provided attribution is given to the place and detail of original publication, as set out in the official citation of the Work published in the journal. The retained right specifically includes the right to post the Work on the authors’ or their institutions’ websites or institutional repository. Disclaimer: The publisher, editors and title owner accept no responsibility for any statement made or opinion expressed by any other person in this Work. Consequently, they will not be liable for any loss or damage sustained by any reader as a result of his or her action upon any statement or opinion in this Work. In cases where a manuscript is NOT accepted for publication by the editorial board, the portions of this agreement regarding the publishing licensing shall be null and void and the authors will be free to submit this manuscript to any other publication for first publication. Our copyright policies are author-friendly and protect the rights of our authors and publishing partners.